DMXU ETF: What Is It? A Complete Guide to Returns, Fees, Holdings, and Alternative ETFs
The Xtrackers MSCI EAFE Selection Equity ETF (DMXU) is a passive ETF that diversifies across large- and mid-cap stocks in developed markets outside the US. The change in its tracking index, its distribution policy, and its fee level are the key selection criteria, and it carries heavy weightings in Europe and Asia-Pacific.
What Is the Xtrackers MSCI EAFE Selection Equity ETF?
This is a core ETF that broadly covers stock markets in developed countries outside the US. It previously followed a selection index in the MSCI EAFE family, but a product overhaul changed its structure so that it now tracks the Bloomberg Developed Markets (ex-US) Core Market Index.
It suits long-term investors who want to add developed-market exposure outside the US to a portfolio that is heavily weighted toward US stocks.
It is an ETF run on a passive (index-tracking) basis, managed by Xtrackers.
How Does the Xtrackers MSCI EAFE Selection Equity ETF Invest?
| Item | Details |
|---|---|
| Tracking index | Bloomberg Developed Markets (ex-US) Core Market Index |
| Management style | Passive (index tracking) |
| Rebalancing frequency | Regular rebalancing under the index rules |
| Dividend/distribution frequency | Not confirmed (check official materials) |
| Expense ratio | 0.03% |
| Manager | Xtrackers |
The fund holds large- and mid-cap stocks in developed markets outside the US at weights close to their market capitalization, following the index's performance. Its structure emphasizes broad exposure to the whole market over stock picking, and the index overhaul has reduced the selection criteria and widened coverage of the core market.
- Core exposure to developed markets outside the US in a single holding
- A product whose character has shifted from a selective approach to a broad core approach
- Regional diversification across Europe and Asia-Pacific
Xtrackers MSCI EAFE Selection Equity ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $59.7M, and the expense ratio is 0.03% per year.
Among products in the same asset class, differences in fees and trading liquidity decide long-term results. Right after an overhaul, trading volume can thin out, so it is worth checking the bid-ask quotes.
Xtrackers MSCI EAFE Selection Equity ETF Performance and Trends
Developed-market stocks outside the US move with the direction of the dollar and with the economies of Europe and Japan. Recently, demand to reduce concentration in the US has been seen lifting interest in this asset class as a whole.
Money seeking inexpensive core overseas exposure keeps flowing steadily into this category. However, because this ETF has only just changed its nature, its fund inflow trend appears to be still taking shape.
Xtrackers MSCI EAFE Selection Equity ETF Strengths and Weaknesses
Its strength is that it covers developed markets outside the US in a single holding, while its weaknesses are the short track record after the overhaul and currency exposure.
💪 Key Strengths
⚠️ Points to Watch
Alternative ETFs and Related Products to the Xtrackers MSCI EAFE Selection Equity ETF
Data on similar products for a comparison table is not available for this fund, so it is better to look at it from an asset class perspective instead of a table. Representative products with the same goal of developed-market exposure outside the US include VEA, IEFA, and SCHF, and the differences between them and this ETF come down to the index family tracked, fees, and trading liquidity. Since this is a newly restructured product, long-term holders are better off comparing costs and tracking error first.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| Vanguard FTSE Developed Markets ETF | $69.78 | +0.6% | $227.6B | 0.03% | 2.44% | +13.9% | |
| iShares Core MSCI EAFE ETF | $96.71 | +0.8% | $189.1B | 0.07% | 3.4% | +8.9% | |
| Vanguard Total International Stock ETF | $83.74 | +0.5% | $161.1B | 0.05% | 2.37% | +11.8% | |
| iShares Core MSCI Emerging Markets ETF | $77.37 | +0.0% | $152.3B | 0.09% | 2.32% | +14.1% | |
| Vanguard FTSE Emerging Markets ETF | $58.25 | +0.4% | $122.7B | 0.06% | 2.09% | +5.8% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| ASML | ASML Holding NV | 0.06% | $1630.84 | -1.0% | $628.6B | 40.2 | 0.65% |
| HSBC | HSBC Holdings plc ADR | 0.03% | $92.74 | -0.2% | $317.8B | 13.3 | 4.49% |
| AZN | Astrazeneca plc | 0.02% | $168.82 | +3.0% | $261.8B | 25.2 | 1.98% |
| NVS | Novartis AG ADR | 0.02% | $153.64 | +2.3% | $281.2B | 23.2 | 2.83% |
| TTE | TotalEnergies SE | 0.02% | $90.08 | +0.1% | $200.4B | 11.1 | 4.45% |
| AllianzIM Growth-100 Buffer5 ETF | 0.01% | $26.68 | -0.1% | $0.0M | - | - | |
| NVO | Novo Nordisk ADR | 0.01% | $39.35 | +2.4% | $131.7B | 9.6 | 4.56% |
| SMFG | Sumitomo Mitsui Financial Group Inc ADR | 0.01% | $24.17 | -1.0% | $303.9B | 27.8 | 2.5% |
| SONY | Sony Group Corp ADR | 0.01% | $25.21 | +1.8% | $148.0B | - | 0.85% |
| UL | Unilever plc ADR | 0.01% | $65.22 | +0.1% | $140.5B | 21.8 | 3.32% |
Xtrackers MSCI EAFE Selection Equity ETF Investor Checkpoints
These are the items to check before adding this ETF. Because the product's nature has just changed, judging it by its old name and index will lead you astray. Start by confirming what it tracks now.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| 🧭 Tracking index | Check the holdings against the post-overhaul index | Bloomberg Developed Markets (ex-US) family |
| 💵 Expense ratio | Check the effect of cumulative costs over a long holding period | Check official materials |
| 💰 Dividends and distributions | Check the distribution frequency and payment history | Frequency not confirmed |
| 💱 Exchange rate | Review the effect on returns converted into won | Not currency hedged |
Because of the index overhaul, past performance cannot fully explain the fund's future character. If currency swings and an economic slowdown in Europe and Japan coincide, short-term losses can grow larger. During hours of thin trading, execution prices can also become less favorable.
It is a workable choice for investors who want developed-market exposure outside the US in a single holding. However, since the overhaul is recent, we recommend deciding only after confirming the fees, tracking error, and distribution policy in official materials.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of September 19, 2026.